The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Diagnostics and Treatment Market Research Report 2025
Synopsis
The global Tuberculosis Diagnostics and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostics and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostics and Treatment.
Report Scope
The Tuberculosis Diagnostics and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Diagnostics and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Diagnostics and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Segment by Type
Skin Testing
Laboratory Testing
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnostics and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Tuberculosis Diagnostics and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostics and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostics and Treatment.
Report Scope
The Tuberculosis Diagnostics and Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Diagnostics and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Diagnostics and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Segment by Type
Skin Testing
Laboratory Testing
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnostics and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Skin Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostics and Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2019-2030)
2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Region
2.2.1 Global Tuberculosis Diagnostics and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis Diagnostics and Treatment Market Dynamics
2.3.1 Tuberculosis Diagnostics and Treatment Industry Trends
2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers
2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges
2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2023
3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type
4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2025-2030)
5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application
5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2019-2030)
6.2 North America Tuberculosis Diagnostics and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2019-2030)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2019-2030)
9.2 Latin America Tuberculosis Diagnostics and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Detail
11.1.2 Cepheid Inc Business Overview
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.1.5 Cepheid Inc Recent Development
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Detail
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.2.5 Becton Dickinson Recent Development
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Detail
11.3.2 Hain LifeSciences Business Overview
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.3.5 Hain LifeSciences Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Alere, Inc
11.5.1 Alere, Inc Company Detail
11.5.2 Alere, Inc Business Overview
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.5.5 Alere, Inc Recent Development
11.6 Roche AG
11.6.1 Roche AG Company Detail
11.6.2 Roche AG Business Overview
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.6.5 Roche AG Recent Development
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Detail
11.7.2 Hologic Corporation Business Overview
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.7.5 Hologic Corporation Recent Development
11.8 bioMerieux
11.8.1 bioMerieux Company Detail
11.8.2 bioMerieux Business Overview
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.8.5 bioMerieux Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.10.5 QIAGEN Recent Development
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Detail
11.11.2 Akonni Biosystems, Inc. Business Overview
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.11.5 Akonni Biosystems, Inc. Recent Development
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Detail
11.12.2 Epistem Holdings Plc Business Overview
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.12.5 Epistem Holdings Plc Recent Development
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Detail
11.13.2 Gen-Probe Inc. Business Overview
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.13.5 Gen-Probe Inc. Recent Development
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Detail
11.14.2 EIKEN Chemical Business Overview
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.14.5 EIKEN Chemical Recent Development
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Detail
11.15.2 Thermo Fisher Scientific, Inc Business Overview
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2019-2024)
11.15.5 Thermo Fisher Scientific, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
